Ascendis Pharma Statistics

Total Valuation

ASND has a market cap or net worth of $7.71 billion. The enterprise value is $8.09 billion.

Market Cap	7.71B
Enterprise Value	8.09B

Important Dates

The last earnings date was Thursday, May 2, 2024, after market close.

Earnings Date	May 2, 2024
Ex-Dividend Date	n/a

Share Statistics

ASND has 56.61 million shares outstanding.

Shares Outstanding	56.61M
Owned by Insiders (%)	0.76%
Owned by Institutions (%)	107.63%
Float	56.90M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	21.57
Forward PS	14.71
PB Ratio	n/a
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	22.62
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.83

Current Ratio	0.83
Quick Ratio	0.49
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-3.13

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-60.30%
Return on Capital (ROIC)	-83.79%
Revenue Per Employee	$406,864
Profits Per Employee	-$620,232
Employee Count	879
Asset Turnover	0.40
Inventory Turnover	0.25

Taxes

In the past 12 months, ASND has paid $9.15 million in taxes.

Income Tax	9.15M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +54.61% in the last 52 weeks. The beta is 0.59, so ASND's price volatility has been lower than the market average.

Beta (5Y)	0.59
52-Week Price Change	+54.61%
50-Day Moving Average	132.69
200-Day Moving Average	124.45
Relative Strength Index (RSI)	56.12
Average Volume (20 Days)	282,689

Short Selling Information

Short Interest	3.46M
Short Previous Month	3.42M
Short % of Shares Out	8.70%
Short % of Float	n/a
Short Ratio (days to cover)	7.15

Income Statement

In the last 12 months, ASND had revenue of $357.63 million and -$545.18 million in losses. Loss per share was -$9.53.

Revenue	357.63M
Gross Profit	302.78M
Operating Income	-388.04M
Pretax Income	-529.98M
Net Income	-545.18M
EBITDA	-381.35M
EBIT	-401.60M
Loss Per Share	-$9.53

Full Income Statement

Balance Sheet

The company has $344.22 million in cash and $719.12 million in debt, giving a net cash position of -$374.90 million or -$6.62 per share.

Cash & Cash Equivalents	344.22M
Total Debt	719.12M
Net Cash	-374.90M
Net Cash Per Share	-$6.62
Equity (Book Value)	-256.02M
Book Value Per Share	-4.52
Working Capital	-144.96M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$453.50 million and capital expenditures -$1.62 million, giving a free cash flow of -$455.12 million.

Operating Cash Flow	-453.50M
Capital Expenditures	-1.62M
Free Cash Flow	-455.12M
FCF Per Share	-$8.00

Full Cash Flow Statement

Margins

Gross margin is 84.66%, with operating and profit margins of -108.50% and -152.44%.

Gross Margin	84.66%
Operating Margin	-108.50%
Pretax Margin	-148.19%
Profit Margin	-152.44%
EBITDA Margin	-106.63%
EBIT Margin	-112.29%
FCF Margin	-127.26%

Dividends & Yields

ASND does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1.41%
Shareholder Yield	-1.41%
Earnings Yield	-7.07%
FCF Yield	-5.90%

Dividend Details

Analyst Forecast

The average price target for ASND is $186.33, which is 36.74% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$186.33
Price Target Difference	36.74%
Analyst Consensus	Strong Buy
Analyst Count	9
Revenue Growth Forecast (5Y)	56.74%
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

ASND has an Altman Z-Score of 2.39 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.39
Piotroski F-Score	3